SCHEMBL4094141

SCHEMBL4094141

COc1ccc2c(c1)c(C(=O)C(=O)NC1CCCCC1)c(C(C)C)n2Cc1ccc(Cl)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.48
ALDH1A1 P00352 2/20 0.48
MEN1 O00255 1/20 0.48
RGS12 O14924 1/20 0.48
LMNA P02545 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
PKM P14618 1/20 0.48
TSHR P16473 1/20 0.48
NFKB1 P19838 1/20 0.48
MAPK1 P28482 1/20 0.48
CYP2C19 P33261 1/20 0.48
GNAI1 P63096 1/20 0.48
PMP22 Q01453 1/20 0.48
KMT2A Q03164 1/20 0.48
HIF1A Q16665 1/20 0.48
PLA2G2A P14555 2/20 0.47
S1PR3 Q99500 2/20 0.44
MCHR1 Q99705 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3006103 0.96 MEN1 (0.50) MAPTALDH1A1MEN1RGS12LMNA
SCHEMBL3001965 0.89 MAPT (0.51) MAPTALDH1A1MEN1RGS12LMNA
SCHEMBL2991276 0.89 ALDH1A1 (0.57) MAPTALDH1A1MEN1RGS12LMNA
SCHEMBL3008192 0.88 ALDH1A1 (0.52) MAPTALDH1A1MEN1RGS12LMNA
SCHEMBL3004246 0.87 ALDH1A1 (0.52) MAPTALDH1A1MEN1RGS12LMNA
SCHEMBL3006378 0.85 PLA2G2A (0.49) MAPTALDH1A1MEN1RGS12LMNA
SCHEMBL3004214 0.85 LMNA (0.53) MAPTALDH1A1MEN1RGS12LMNA
SCHEMBL3006515 0.84 PLA2G2A (0.49) MAPTALDH1A1MEN1RGS12LMNA
SCHEMBL4083920 0.84 ALDH1A1 (0.60) MAPTALDH1A1MEN1RGS12LMNA
SCHEMBL3006366 0.83 PLA2G2A (0.49) MAPTALDH1A1MEN1RGS12LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090118503-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. 2009-05-07 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118503-A1 FAAH INHIBITORS FAAH, FAAH2, CNR2 MAPT 2737/4885ALDH1A1 648/4885MEN1 4573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.